Vea MedIQ en Español
The Impact of Complete Revascularization in the ISCHEMIA Trial study was a pre-specified sub-study of the ISCHEMIA clinical trial (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches). Among patients with chronic coronary artery disease (CAD) without prior myocardial revascularization, randomized to invasive treatment (surgical or percutaneous) versus conservative treatment in the original study, the authors prospectively evaluated: 1) the outcomes of complete anatomical revascularization (CAR) or complete functional revascularization (CFR) compared to incomplete revascularization, and 2) the potential impact of complete revascularization (CR) in all patients in the intervention arm compared to conservative management.
Complete Revascularization versus Optimal Medical Therapy Alone In Chronic Coronary Syndrome: A Sub-Analysis from the ISCHEMIA Trial
Escrito por: Flávia Bittar Brito Arantes em 27 de outubro de 2023
5 min de leitura
Referência
Stone GW, Ali ZA, O’Brien SM et al, em nome do Grupo de Pesquisa ISCHEMIA. Impacto da revascularização completa no ensaio ISCHEMIA. JACC , 2023; 82:1175–1188.
Sobre o autor
Flávia Bittar Brito Arantes
Professora Adjunta da Faculdade de Medicina da Universidade Federal de Uberlândia, Docente na Faculdade IMEPAC e Coordenadora Médica do Centro de Pesquisa Eurolatino em Uberlândia
